These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28712747)

  • 1. Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia.
    She A; Kurtser I; Reis SA; Hennig K; Lai J; Lang A; Zhao WN; Mazitschek R; Dickerson BC; Herz J; Haggarty SJ
    Cell Chem Biol; 2017 Jul; 24(7):892-906.e5. PubMed ID: 28712747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic Tuning of HDAC Inhibitors Affords Potent Inducers of Progranulin Expression.
    Moreno-Yruela C; Fass DM; Cheng C; Herz J; Olsen CA; Haggarty SJ
    ACS Chem Neurosci; 2019 Aug; 10(8):3769-3777. PubMed ID: 31330099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients.
    Almeida S; Gao F; Coppola G; Gao FB
    Neurobiol Aging; 2016 Jun; 42():35-40. PubMed ID: 27143419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects.
    Almeida S; Zhang Z; Coppola G; Mao W; Futai K; Karydas A; Geschwind MD; Tartaglia MC; Gao F; Gianni D; Sena-Esteves M; Geschwind DH; Miller BL; Farese RV; Gao FB
    Cell Rep; 2012 Oct; 2(4):789-98. PubMed ID: 23063362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
    Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
    Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia.
    Raitano S; Ordovàs L; De Muynck L; Guo W; Espuny-Camacho I; Geraerts M; Khurana S; Vanuytsel K; Tóth BI; Voets T; Vandenberghe R; Cathomen T; Van Den Bosch L; Vanderhaeghen P; Van Damme P; Verfaillie CM
    Stem Cell Reports; 2015 Jan; 4(1):16-24. PubMed ID: 25556567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by
    Holler CJ; Taylor G; Deng Q; Kukar T
    eNeuro; 2017; 4(4):. PubMed ID: 28828399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
    Ward ME; Chen R; Huang HY; Ludwig C; Telpoukhovskaia M; Taubes A; Boudin H; Minami SS; Reichert M; Albrecht P; Gelfand JM; Cruz-Herranz A; Cordano C; Alavi MV; Leslie S; Seeley WW; Miller BL; Bigio E; Mesulam MM; Bogyo MS; Mackenzie IR; Staropoli JF; Cotman SL; Huang EJ; Gan L; Green AJ
    Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.
    Valdez C; Wong YC; Schwake M; Bu G; Wszolek ZK; Krainc D
    Hum Mol Genet; 2017 Dec; 26(24):4861-4872. PubMed ID: 29036611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency.
    Lee WC; Almeida S; Prudencio M; Caulfield TR; Zhang YJ; Tay WM; Bauer PO; Chew J; Sasaguri H; Jansen-West KR; Gendron TF; Stetler CT; Finch N; Mackenzie IR; Rademakers R; Gao FB; Petrucelli L
    Hum Mol Genet; 2014 Mar; 23(6):1467-78. PubMed ID: 24163244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
    Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.
    Cenik B; Sephton CF; Dewey CM; Xian X; Wei S; Yu K; Niu W; Coppola G; Coughlin SE; Lee SE; Dries DR; Almeida S; Geschwind DH; Gao FB; Miller BL; Farese RV; Posner BA; Yu G; Herz J
    J Biol Chem; 2011 May; 286(18):16101-8. PubMed ID: 21454553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia.
    Rosenthal ZC; Fass DM; Payne NC; She A; Patnaik D; Hennig KM; Tesla R; Werthmann GC; Guhl C; Reis SA; Wang X; Chen Y; Placzek M; Williams NS; Hooker J; Herz J; Mazitschek R; Haggarty SJ
    Sci Rep; 2024 Apr; 14(1):9064. PubMed ID: 38643236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
    Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
    Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
    Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
    Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial.
    Ljubenkov PA; Edwards L; Iaccarino L; La Joie R; Rojas JC; Koestler M; Harris B; Boeve BF; Borroni B; van Swieten JC; Grossman M; Pasquier F; Frisoni GB; Mummery CJ; Vandenberghe R; Le Ber I; Hannequin D; McGinnis SM; Auriacombe S; Onofrj M; Goodman IJ; Riordan HJ; Wisniewski G; Hesterman J; Marek K; Haynes BA; Patzke H; Koenig G; Hilt D; Moebius H; Boxer AL
    JAMA Netw Open; 2021 Sep; 4(9):e2125584. PubMed ID: 34559230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hiPSC-derived GRN-deficient astrocytes delay spiking activity of developing neurons.
    Lee C; Frew J; Weilinger NL; Wendt S; Cai W; Sorrentino S; Wu X; MacVicar BA; Willerth SM; Nygaard HB
    Neurobiol Dis; 2023 Jun; 181():106124. PubMed ID: 37054899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progranulin as a therapeutic target for dementia.
    Galimberti D; Fenoglio C; Scarpini E
    Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.